| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10962842 | Vaccine | 2016 | 6 Pages |
Abstract
The results indicated the recombinant protein CP40 induced an specific immune response in mice that was able to afford protection after challenge, regardless the adjuvant used in the formulation.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Daniela Droppa-Almeida, Wanessa L.P. Vivas, Katharina Kelly O. Silva, Andrea F.S. Rezende, Simone Simionatto, Roberto Meyer, Isabel B. Lima-Verde, Odir Delagostin, Sibele Borsuk, Francine F. Padilha,